Staff and students are invited to join us for today’s cyber security seminar on:
‘Persuasive Technology for Information Security’
Tuesday, 27th January at 4pm.
Room: P335 LT
In the seminar, participants will hear about design principles for persuasive technology for promoting information security and also about methods to evaluate persuasive technology. Concrete examples and “best practices” will be given from a recent research project, in which it is used in organizations to make employees comply with information security policies.
Our speaker will be Marc Busch. Marc is a scientist at the AIT – Austrian Institute of Technology and is active at the intersection of persuasive technology and usable privacy and security. Furthermore, he is specialized in advanced quantitative and qualitative usability and user experience methodology, research methods and statistics in Human-computer interaction. Marc is involved in several international and national research and industrial projects, such as MUSES – Multiplatform Usable Endpoint Security Before joining AIT, Marc was at CURE – Center for Usability Research & Engineering, where he focused on user experience and usability.












National Research Supervision Recognition: Apply Now & Join the Supporting Workshop on 16 September
3C Event: ECR Network Café – Wednesday 16 September 2-3pm
BU geography student’s undergraduate dissertation published in international journal
Why some commons survive and others don’t
BU Research blog in 2023 grows into 2026 publication
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease